Biorestorative Therapies Inc (BRTX) 0.4299 $BRTX
BioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York
Business Wire - Tue Apr 14, 6:45AM CDT
BioRestorative Therapies, Inc. ("BRT" or "the Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announced today that the Company has relocated its corporate, administrative and laboratory operations to Melville, Long Island, New York.
BioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors
Business Wire - Wed Apr 08, 7:52AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, today announced the appointment of Charles S. Ryan, J.D., Ph.D. to its Board of Directors.
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Business Wire - Tue Feb 17, 7:02AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Edward Field has been appointed as President of the Company's brtxDISC(TM) Division.
BioRestorative Therapies, Inc. to Present at Inaugural Innovations Conference
Business Wire - Thu Feb 05, 7:27AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, announced that it will be presenting at The Brewer Group's ("TBG" inaugural Innovations Conference in Miami on Monday, February 9, 2015 at The Mondrian South Beach.
BioRestorative Therapies Appoints Dr. Joy Cavagnaro to Scientific Advisory Board
Business Wire - Mon Feb 02, 6:50AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Joy Cavagnaro, Ph.D., DABT, RAC, has been appointed as a member of the Company's Scientific Advisory Board.
BioRestorative Therapies Reports Successful Meeting with FDA
Business Wire - Mon Jan 12, 7:09AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, announced that it has had a successful pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (the "FDA" concerning its lead therapeutic product, brtxDISC(TM), to be used in a non-surgical treatment for chronic lumbar disc disease.
BioRestorative Therapies Schedules Pre-IND Meeting with FDA
Business Wire - Mon Nov 24, 7:30AM CST
--Clinical Development Meeting with FDA
BioRestorative Therapies Engages Access BIO to Support Advancement of brtxDISC(TM) Program into Clinical Studies
Business Wire - Thu Oct 09, 8:04AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announces the engagement of Access BIO, L.C. to provide strategic preclinical and regulatory consulting services related to the Company's brtxDISC(TM) program. Initially Access BIO will help the Company prepare for pre-Investigational New Drug (IND) and IND meetings with the U.S. Food and Drug Administration (FDA). This represents the next stage in advancing the Company's brtxDISC(TM) procedure into the clinic.
BioRestorative Therapies Announces Relocation To New York State
Business Wire - Wed Sep 03, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced it has been awarded up to $500,000 in performance-based Excelsior Tax Credits from Empire State Development ("ESD", New York State's economic development agency, as part of a relocation incentive package from the State, as well an estimated $146,000 of sales tax exemptions and property tax abatement from the Suffolk County Industrial Development Agency ("IDA".
BioRestorative Therapies Engages Consulting Firm to Develop Strategic Partnerships in Japan and China
Business Wire - Mon Aug 18, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced the engagement of Tokyo-based Solution Partners Ltd. to develop strategic alliances in Japan and China for the Company's technologies. The agreement includes introductions to potential strategic partners and other alliance candidates, with the goal of expansion and development of the Company's ThermoStem(R) program, the Company's stem cell delivery device used in connection with the Company's brtx-DISC(TM) program and the Company's brtx-C Cosmetic program.
BioRestorative Therapies Issues Letter to Stockholders
Business Wire - Mon Jul 14, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, has issued a letter to stockholders, the text of which is below.
BioRestorative Therapies Appoints Joseph B. Swiader to its Board of Directors
Business Wire - Wed Jul 02, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB: BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of Joseph B. Swiader, age 54, to its Board of Directors. Mr. Swiader will chair the Nominating Committee and serve on the Compensation Committee of the Board.
BioRestorative Therapies Appoints The Honorable Paul Jude Tonna to its Board of Directors
Business Wire - Mon Jun 30, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company" (OTCBB:BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of The Honorable Paul Jude Tonna to its Board of Directors. Mr. Tonna will serve on the Audit, Compensation and Nominating committees of the Board.
BioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York
Business Wire - Tue Apr 14, 6:45AM CDT
BioRestorative Therapies, Inc. ("BRT" or "the Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announced today that the Company has relocated its corporate, administrative and laboratory operations to Melville, Long Island, New York. BioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors
Business Wire - Wed Apr 08, 7:52AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, today announced the appointment of Charles S. Ryan, J.D., Ph.D. to its Board of Directors. BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Business Wire - Tue Feb 17, 7:02AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Edward Field has been appointed as President of the Company's brtxDISC(TM) Division. BioRestorative Therapies, Inc. to Present at Inaugural Innovations Conference
Business Wire - Thu Feb 05, 7:27AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB: BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, announced that it will be presenting at The Brewer Group's ("TBG" inaugural Innovations Conference in Miami on Monday, February 9, 2015 at The Mondrian South Beach. BioRestorative Therapies Appoints Dr. Joy Cavagnaro to Scientific Advisory Board
Business Wire - Mon Feb 02, 6:50AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Joy Cavagnaro, Ph.D., DABT, RAC, has been appointed as a member of the Company's Scientific Advisory Board. BioRestorative Therapies Reports Successful Meeting with FDA
Business Wire - Mon Jan 12, 7:09AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB: BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, announced that it has had a successful pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (the "FDA" concerning its lead therapeutic product, brtxDISC(TM), to be used in a non-surgical treatment for chronic lumbar disc disease. BioRestorative Therapies Schedules Pre-IND Meeting with FDA
Business Wire - Mon Nov 24, 7:30AM CST
--Clinical Development Meeting with FDA
BioRestorative Therapies Engages Access BIO to Support Advancement of brtxDISC(TM) Program into Clinical Studies
Business Wire - Thu Oct 09, 8:04AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announces the engagement of Access BIO, L.C. to provide strategic preclinical and regulatory consulting services related to the Company's brtxDISC(TM) program. Initially Access BIO will help the Company prepare for pre-Investigational New Drug (IND) and IND meetings with the U.S. Food and Drug Administration (FDA). This represents the next stage in advancing the Company's brtxDISC(TM) procedure into the clinic. BioRestorative Therapies Announces Relocation To New York State
Business Wire - Wed Sep 03, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced it has been awarded up to $500,000 in performance-based Excelsior Tax Credits from Empire State Development ("ESD", New York State's economic development agency, as part of a relocation incentive package from the State, as well an estimated $146,000 of sales tax exemptions and property tax abatement from the Suffolk County Industrial Development Agency ("IDA". BioRestorative Therapies Engages Consulting Firm to Develop Strategic Partnerships in Japan and China
Business Wire - Mon Aug 18, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced the engagement of Tokyo-based Solution Partners Ltd. to develop strategic alliances in Japan and China for the Company's technologies. The agreement includes introductions to potential strategic partners and other alliance candidates, with the goal of expansion and development of the Company's ThermoStem(R) program, the Company's stem cell delivery device used in connection with the Company's brtx-DISC(TM) program and the Company's brtx-C Cosmetic program. BioRestorative Therapies Issues Letter to Stockholders
Business Wire - Mon Jul 14, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, has issued a letter to stockholders, the text of which is below. BioRestorative Therapies Appoints Joseph B. Swiader to its Board of Directors
Business Wire - Wed Jul 02, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB: BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of Joseph B. Swiader, age 54, to its Board of Directors. Mr. Swiader will chair the Nominating Committee and serve on the Compensation Committee of the Board. BioRestorative Therapies Appoints The Honorable Paul Jude Tonna to its Board of Directors
Business Wire - Mon Jun 30, 7:01AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"
(OTCBB:BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of The Honorable Paul Jude Tonna to its Board of Directors. Mr. Tonna will serve on the Audit, Compensation and Nominating committees of the Board. 
